Page last updated: 2024-08-24

coproporphyrin i and Chronic Kidney Diseases

coproporphyrin i has been researched along with Chronic Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chu, X; Galetin, A; Ogungbenro, K; Scotcher, D; Takita, H; Yee, KL1
Ando, T; Itoh, H; Mimata, H; Ohno, K; Ono, H; Sasamoto, Y; Shin, T; Suzuki, Y; Tanaka, R; Yoshijima, C1

Other Studies

2 other study(ies) available for coproporphyrin i and Chronic Kidney Diseases

ArticleYear
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.
    Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:3

    Topics: Biomarkers; Coproporphyrins; Drug Interactions; Humans; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Prospective Studies; Renal Insufficiency, Chronic; Rifampin

2022
Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2020, May-30, Volume: 184

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coproporphyrins; Female; Furans; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Plasma; Propionates; Renal Insufficiency, Chronic; Solid Phase Extraction; Tandem Mass Spectrometry; Young Adult

2020